The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant HER2-targeted therapy ± immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial.
 
Heather L. McArthur
Consulting or Advisory Role - AstraZeneca; Crown Bioscience; Gilead Sciences; Immunomedics; Lilly; Merck; Pfizer; Puma Biotechnology; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); ZIOPHARM Oncology (Inst)
 
Jorge Leal
No Relationships to Disclose
 
Stephen Lawrence Shiao
Research Funding - Merck
 
Meredith Carter
No Relationships to Disclose
 
Reva K Basho
Employment - Alignment Healthcare (I); Apollo Medical Holdings (I); Lawrence J. Ellison Institute for Transformative Medicine
Stock and Other Ownership Interests - Alignment Healthcare (I); Apollo Medical Holdings (I); Fresenius (I)
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Pfizer; Pfizer; Seagen
Speakers' Bureau - Lilly
Research Funding - Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); Takeda (Inst)
Other Relationship - MJH Healthcare Holdings, LLC; WebMD/Medscape
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Genentech; Novartis; Pfizer
 
Michelle Phillips
No Relationships to Disclose
 
David Chan
No Relationships to Disclose
 
Hugo Hool
Stock and Other Ownership Interests - Abbvie; Acceleron Pharma; Adverum; Affimed Therapeutics; Agios; Agios; Allergan; Amgen; BeiGene; Bluebird Bio; Bristol-Myers Squibb; Daiichi Sankyo CO; Daiichi Sankyo/UCB Japan; Entera Bio; Forty Seven; Genomic Health; Geron; Gilead Sciences; Health Without Borders; Humanigen; Immunogen; Immunomedics; Kura Oncology; Lilly; Merck; Mirati Therapeutics; Novartis; Procept Biorobotics; RAPT Therapeutics; Regeneron; Roche; Seagen; Sorrento Therapeutics; Takeda; Valeant Pharmaceuticals International
Research Funding - ARMO BioSciences (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Halozyme (Inst); Incyte (Inst); Pfizer (Inst); syndax (Inst)
Other Relationship - Cedars-Sinai; TRIO US
 
Dorothy J. Park
No Relationships to Disclose
 
Mary El-Masry
No Relationships to Disclose
 
Philomena McAndrew
No Relationships to Disclose
 
Swati Sikaria
No Relationships to Disclose
 
Laura Spring
Consulting or Advisory Role - AstraZeneca; Daiichi Pharma; G1 Therapeutics; Novartis; Puma Biotechnology
Research Funding - Genentech/Roche; Gilead Sciences; Lilly; Merck (Inst); Philips Healthcare (Inst)
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo/Astra Zeneca; Foundation Medicine; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Philips Healthcare; Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Mourad Tighiouart
No Relationships to Disclose
 
Farnaz Dadmanesh
No Relationships to Disclose
 
Armando E. Giuliano
Stock and Other Ownership Interests - Blacklight Surgical
Honoraria - Merck/Schering Plough
 
Katherine Sanchez
No Relationships to Disclose
 
David B. Page
Consulting or Advisory Role - Brooklyn ImmunoTherapeutics; Genentech/Roche; Puma Biotechnology
Speakers' Bureau - Genentech; Novartis
Research Funding - Bristol-Myers Squibb; Brooklyn ImmunoTherapeutics; MedImmune (Inst); Merck
Expert Testimony - Philips Healthcare